A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects

NCT06141577 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD

Interventions

DRUG: UI059
DRUG: UIC202201

Sponsor

Korea United Pharm. Inc.